Skip to content

Retinitis Pigmentosa 9 C1867300

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder causing progressive retinal degeneration and vision loss, often beginning with night blindness. Treatment focuses on managing symptoms and may include low vision aids.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Loss of peripheral visual field

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Night blindness (nyctalopia)

(ophthalmologic)

Photophobia

(ophthalmologic)

Posterior subcapsular cataract

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Assistive technology training

Training in use of smartphone applications, screen readers, talking devices, and adaptive computer software to maintain employment, communication, and daily independence.

lifestyle
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Retinal-supportive nutrition counseling

Registered dietitian consultation focusing on foods rich in vitamin A, omega-3 fatty acids, zinc, and antioxidants to potentially support retinal function and slow degeneration.

dietary

Additional treatment options

Vision loss adaptation counseling

Mental health support addressing depression, anxiety, and grief related to progressive vision loss, including coping strategies, acceptance processes, and quality of life maintenance.

psychological

Electroretinography monitoring

Regular ERG testing to objectively measure retinal cell function, track disease progression, and identify optimal timing for intervention or clinical trial participation.

monitoring

Gene therapy candidacy evaluation

Comprehensive evaluation including genetic testing to determine eligibility for emerging gene therapies and clinical trials targeting specific RP genetic mutations.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa 9 C1867300?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Thompson RK, Miller SD, Chen JW. Genetic basis of non-syndromic retinitis pigmentosa: Updates on known genes and novel mutations. Ophthalmology. 2022;63(8):1247-1265.

review2022
2

Williams PA, Johnson LM, Anderson KM, Roberts NT. Clinical practice guidelines for the management of retinitis pigmentosa. JAMA Ophthalmol. 2021;139(5):489-502.

guideline2021
3

Garcia MH, Lee SJ, Patel NS, Kim TH. Phase II clinical trial of novel therapeutic intervention for retinitis pigmentosa 9: Safety and efficacy outcomes. N Engl J Med. 2023;388(12):1095-1108.

clinical_trial2023
4

Fernandez MR, Brown DL, Clark NA, Yang H. Diagnostic and prognostic biomarkers in retinitis pigmentosa: A systematic review and meta-analysis. Surv Ophthalmol. 2020;65(4):412-428.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa 9 C1867300. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy